Calcium carbonate surface calcium sites (CaCO3 surface)

Calcium carbonate surface calcium sites refer to the exposed divalent calcium cations on the crystal faces of calcium carbonate polymorphs, such as calcite or aragonite. These sites are critical in the process of biomineralization, where they interact with organic matrices, proteins, and small molecules to regulate crystal nucleation and growth [1]. In clinical pharmacology, these surface sites are the primary targets for crystallization inhibitors, including bisphosphonates and polyphosphates, which bind to the Ca2+ ions to prevent the formation of pathological calcifications [2, 4]. While calcium carbonate is less common than hydroxyapatite in human physiology, it is a significant component of certain types of calculi and is used extensively as a therapeutic agent for acid neutralization and calcium supplementation [3]. Drugs interacting with these sites typically function by adsorbing onto active growth centers, such as kinks and steps on the crystal surface, thereby sterically hindering the addition of further carbonate and calcium ions [1, 4]. This mechanism is essential for managing conditions related to abnormal mineral deposition and for the development of antiscalants in medical and industrial applications [1, 2]. Furthermore, the study of these sites is vital for understanding the pharmacokinetics of calcium-based supplements and their transition into the systemic circulation [3]. The interaction at these sites is often characterized by high affinity and specificity for phosphonate and carboxylate functional groups [2, 4].

Other names

Calcite surfaceAragonite surfaceCalcium carbonate crystal surfaceCaCO3 surface

Crystal growth inhibition via surface adsorption to active growth sites (kinks and steps), preventing the incorporation of additional ions into the mineral lattice.